Takayasu Arteritis: Current Perspective and Brief Narrative Review

  • Amanpreet Singh Wasir, Dr. Ravi Kalra, Dr. John D’Souza
Keywords: COVID-19, diagnosis, endovascular, giant cell arteritis, interventions, takayasu arteritis, treatment

Abstract

Takayasu Arteritis (TA) is a rare chronic inflammatory vascular disorder that mainly causes stenosis and occlusion of large vessels of the body. TA is prevalent in the Asian population with a higher evidence seen in young females. Even though TA has an unclear etiopathogenesis, there are numerous genetic links found associated with TA. Various interventional and radiological investigations prove to be the key for confirming the diagnosis of TA, following which appropriate medical and surgical line of treatment are done, however there is no universal protocol for managing TA. TA has a tendency to progress to serious life threatening complications, hence early diagnosis and treatment should be the goal, also aimed at preventing future re-stenosis, a well-studied complication of TA. It is also crucial to diagnose TA from other overlapping diseases, owing to its peculiar clinical presentation and characteristic radiological findings, which is often confused with other vascular disorders. TA as a disease greatly impacts the quality of life in affected patients with a worse prognosis seen in those who are
predisposed to certain well documented risk factors. Furthermore, an increasing number of cases reporting an interesting link between arteritis and the COVID-19 virus have been reported in recent times, which might prove to be crucial in the forthcoming years for establishing this association. Our article aims to sensitize clinicians with regard to an increased awareness of TA in various clinical settings for better patient management and improved prognosis.

References

1. Mason JC. Takayasu arteritis--advances in diagnosis and management. Nat Rev Rheumatol. 2010 Jul;6(7):406-15.
2. Numano F. The story of Takayasu arteritis. Rheumatology (Oxford). 2002 Jan;41(1):103-6.
3. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen
S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013 Jan;65(1):1-11.
Published
2022-06-03
How to Cite
Amanpreet Singh Wasir, Dr. Ravi Kalra, Dr. John D’Souza. (2022). Takayasu Arteritis: Current Perspective and Brief Narrative Review. The Indian Practitioner, 75(5), 18-23. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/1366